SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 155 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $135,000 | -72.8% | 44,250 | -58.7% | 0.09% | -72.2% |
| Q3 2016 | $496,000 | -31.1% | 107,145 | -13.9% | 0.32% | -34.8% |
| Q2 2016 | $720,000 | -4.4% | 124,395 | 0.0% | 0.50% | -5.0% |
| Q1 2016 | $753,000 | -35.3% | 124,395 | -2.4% | 0.52% | -36.1% |
| Q4 2015 | $1,163,000 | +69.8% | 127,395 | +4.9% | 0.82% | +97.3% |
| Q3 2015 | $685,000 | -45.9% | 121,445 | +6.4% | 0.42% | -38.1% |
| Q2 2015 | $1,266,000 | -29.2% | 114,120 | 0.0% | 0.67% | -26.9% |
| Q1 2015 | $1,789,000 | +4.5% | 114,120 | +1.4% | 0.92% | -3.3% |
| Q4 2014 | $1,712,000 | +54.5% | 112,540 | +9.5% | 0.95% | +33.9% |
| Q3 2014 | $1,108,000 | -26.5% | 102,765 | +4.1% | 0.71% | -32.2% |
| Q2 2014 | $1,508,000 | +9.8% | 98,765 | +30.0% | 1.04% | +4.7% |
| Q1 2014 | $1,373,000 | +58.7% | 75,950 | +22.0% | 1.00% | +43.9% |
| Q4 2013 | $865,000 | +23.2% | 62,250 | -7.0% | 0.69% | +8.0% |
| Q3 2013 | $702,000 | +444.2% | 66,950 | +305.8% | 0.64% | +416.9% |
| Q2 2013 | $129,000 | – | 16,500 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |